Drug-Drug Interactions in Patients with COVID-19 in Nursing Homes

被引：0
|
作者：
Correard, Florian [1 ]
Couderc, Anne-Laure [2 ]
Arcani, Robin [2 ]
Weiland, Joris [2 ]
Courcier, Anais [2 ]
Berard, Charlotte [1 ]
Miola, Charlene [2 ]
Berbis, Julie [3 ]
Villani, Patrick [2 ]
Daumas, Aurelie [2 ]
机构：
[1] Aix Marseille Univ, Timone Hosp, AP HM, Pharmaceut Expertise & Clin Res Unit,Pharm Dept, Marseille, France
[2] Aix Marseille Univ, Timone & St Marguerite Hosp, AP HM, Internal Med Geriatry & Therapeut Dept,CHU Timone, 264 Rue St Pierre, F-13384 Marseille, France
[3] Aix Marseille Univ, Sch Med, EA 3279, CEReSS Hlth Serv Res & Qual Life Ctr, La Timone Med Campus, Marseille, France
来源：
DRUGS & AGING | 2021年 / 38卷 / 07期
关键词：
D O I：
10.1007/s40266-021-00854-6
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
下载
收藏
页码：633 / 635
页数：3
相关论文
共 50 条
  • [1] Drug–Drug Interactions in Patients with COVID-19 in Nursing Homes
    Florian Correard
    Anne-Laure Couderc
    Robin Arcani
    Joris Weiland
    Anais Courcier
    Charlotte Berard
    Charlène Miola
    Julie Berbis
    Patrick Villani
    Aurélie Daumas
    Drugs & Aging, 2021, 38 : 633 - 635
  • [2] Drug-drug interactions in patients with COVID-19
    Reactions Weekly, 2020, 1831 (1) : 8 - 8
  • [3] POTENTIAL DRUG-DRUG INTERACTIONS IN HOSPITALIZED PATIENTS WITH COVID-19
    Szkutnik-Fiedler, Danuta
    Kwiatkowski, Filip
    Chomej, Monika
    Kolodziej, Dorota
    Michalak, Michal
    Grzeskowiak, Edmund
    Szalek, Edyta
    ACTA POLONIAE PHARMACEUTICA, 2023, 80 (02): : 277 - 287
  • [4] Why Are Patients With COVID-19 at Risk for Drug-Drug Interactions?
    Preskorn, Sheldon H.
    Quadri, Syeda
    JOURNAL OF PSYCHIATRIC PRACTICE, 2020, 26 (06) : 485 - 492
  • [5] Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
    Spanakis, Marios
    Ioannou, Petros
    Tzalis, Sotiris
    Papakosta, Vasiliki
    Patelarou, Evridiki
    Tzanakis, Nikos
    Patelarou, Athina
    Kofteridis, Diamantis P. P.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [6] COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions
    Back, David
    Marzolini, Catia
    Hodge, Catherine
    Marra, Fiona
    Boyle, Alison
    Gibbons, Sara
    Burger, David
    Khoo, Saye
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (01) : 212 - 213
  • [7] Drug-Drug Interactions and the Clinical Tolerability of Colchicine Among Patients With COVID-19
    Alfehaid, Lama S.
    Farah, Subrina
    Omer, Azza
    Weber, Brittany N.
    Alkhezi, Omar
    Tawfik, Yahya M. K.
    Shah, Amil M.
    Libby, Peter
    Buckley, Leo F.
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [8] Drug-drug interactions between COVID-19 drug therapies and antidepressants
    Davoutis, Efstathia
    Panou, Chrysa
    Stachika, Nikolina
    Dalla, Christina
    Kokras, Nikolaos
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (12) : 937 - 950
  • [9] Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
    Kilit, Turkan Pasali
    Ozyigit, Filiz
    Erarslan, Sertas
    Onbasi, Kevser
    AFRICAN HEALTH SCIENCES, 2022, 22 (04) : 597 - 606
  • [10] Efficacy, Safety, and Drug-Drug Interactions for Insomnia Therapy in COVID-19 Patients
    Saputra, Billy Dwi
    Levita, Jutti
    Mustarichie, Resmi
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2022, 15 : 137 - 152
12345